Avantax Advisory Services Inc. Takes $248,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Avantax Advisory Services Inc. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,131 shares of the company’s stock, valued at approximately $248,000.

Several other large investors have also modified their holdings of the stock. Operose Advisors LLC acquired a new stake in Tempus AI during the 4th quarter worth $25,000. Cherry Tree Wealth Management LLC acquired a new stake in Tempus AI during the 1st quarter worth $31,000. Continuum Advisory LLC acquired a new stake in Tempus AI during the 1st quarter worth $39,000. Bartlett & CO. Wealth Management LLC boosted its stake in Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after purchasing an additional 400 shares during the period. Finally, Signaturefd LLC acquired a new stake in Tempus AI during the 1st quarter worth $48,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

TEM has been the subject of a number of analyst reports. Morgan Stanley upped their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the stock an “overweight” rating in a research report on Friday, May 9th. Piper Sandler restated a “neutral” rating on shares of Tempus AI in a research report on Friday. BTIG Research initiated coverage on shares of Tempus AI in a research report on Friday. They set a “buy” rating and a $60.00 price objective for the company. Bank of America upped their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 25th. Finally, Guggenheim increased their price target on shares of Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a report on Monday, June 30th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $65.09.

Insider Transactions at Tempus AI

In other Tempus AI news, Director Jennifer A. Doudna sold 625 shares of the business’s stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $62.52, for a total transaction of $39,075.00. Following the completion of the sale, the director owned 26,554 shares in the company, valued at $1,660,156.08. The trade was a 2.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Theodore Leonsis sold 205,847 shares of the company’s stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the transaction, the director owned 15,511 shares of the company’s stock, valued at $1,049,474.26. This represents a 92.99% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 758,772 shares of company stock valued at $51,005,175 over the last ninety days. 27.60% of the stock is currently owned by corporate insiders.

Tempus AI Trading Up 3.6%

Shares of TEM stock opened at $60.87 on Friday. The stock has a market cap of $10.54 billion, a price-to-earnings ratio of -7.80 and a beta of 4.98. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45. The firm’s 50 day moving average price is $62.47 and its two-hundred day moving average price is $58.00.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. During the same period in the previous year, the company posted ($6.86) earnings per share. The business’s revenue for the quarter was up 89.5% compared to the same quarter last year. On average, analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.